B Group, Inc.
Institutional manager — quarterly 13F holdings, Q ending 2026-03-31
Reported value
$134.9M
Q ending 2026-03-31
Prior quarter
$135.4M
Q ending 2025-12-31
Change
-0.4% QoQ · +15.6% YoY
Positions
20
reported holdings
Largest positions
All 20 reported positions, Q ending 2026-03-31. A manager can hold shares, calls and puts on the same security at once — such positions are listed as separate rows. Type: Shares = common stock, Put/Call = option positions (valued at the underlying), Principal = debt. Tickers link to stock pages where covered.
| Holding | Ticker | Type | Value ▼ | Shares |
|---|---|---|---|---|
| Adma Biologics Inc | ADMA | Shares | $28.9M | 3.2M |
| Palisade Bio Inc | PALI | Shares | $20.0M | 11.4M |
| Praxis Precision Medicines I | PRAX | Shares | $10.7M | 33K |
| Cellectis S A | CLLS | Shares | $10.4M | 3.3M |
| Zai Lab Ltd | ZLAB | Shares | $8.5M | 451K |
| Taysha Gene Therapies Inc | TSHA | Shares | $8.0M | 1.8M |
| Nrx Pharmaceuticals Inc | NRXP | Shares | $6.4M | 3.0M |
| Structure Therapeutics Inc | GPCR | Shares | $6.1M | 128K |
| Iovance Biotherapeutics Inc | IOVA | Shares | $5.3M | 1.5M |
| Spyre Therapeutics Inc | SYRE | Shares | $5.0M | 100K |
| Bright Minds Biosciences Inc | DRUG | Shares | $4.9M | 68K |
| Assembly Biosciences Inc | ASMB | Shares | $4.9M | 176K |
| Aura Biosciences Inc | AURA | Shares | $4.0M | 598K |
| Oruka Therapeutics Inc | ORKA | Shares | $3.7M | 75K |
| Sight Sciences Inc | SGHT | Shares | $3.7M | 970K |
| Ultragenyx Pharmaceutical In | RARE | Shares | $2.8M | 135K |
| Apogee Therapeutics Inc | APGE | Shares | $631K | 8K |
| Foghorn Therapeutics Inc | FHTX | Shares | $488K | 102K |
| Soleno Therapeutics Inc | SLNOEUR | Shares | $251K | 8K |
| Replimune Group Inc | REPL | Shares | $199K | 26K |
Values as reported in public regulatory filings (USD); holdings are reported quarterly, up to 45 days after quarter end, and may contain reporting errors. Nothing here is investment advice.